Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2726-2730

  Branet, Florence ^a   Brousset, Pierre ^b   Krajewski, Stanislaw ^c   Schlaifer, Daniel ^b   Selves, Janick ^b   Reed, John C ^c,d   Caron, Philippe ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

^c BURNHAM INSTITUTE   (United States)

^d The Leukemia & Lymphoma Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA, PAPILLARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; THYROID NEOPLASMS;

EID: 0029906324     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2726     Document Type: Article

References (31)

1. Williams GT, Smith CA. 1993 Molecular regulation of apoptosis: genetic controls on cell death. Cell. 74:777-779.
2. Wyllie AH, Kerr JFR, Currie AR. 1980 Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306.
3. Reed JC. 1994 Bcl-2 and the regulation of programmed cell death. J Cell Biol. 124:1-6.
4. Cleary ML, Smith SD, Sklar J. 1986 Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:19-28.
5. Tsujimoto Y, Croce CM. 1986 Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 83:5214-5218.
6. Boise LH, Gonzalez-Garcia M, Postema CE, et al. 1993 Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
7. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. 1993 MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA. 90:3516-3520.
8. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609-619.
9. Sato T, Hanada M, Bodrug S, et al. 1994 Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA. 91:9238-9242.
10. Hanada M, Aimé-Sempé C, Sato T, Reed JC. 1995 Structure-function analysis of Bcl-2 protein: identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with bax. J Biol Chem. 270:11962-11969.
11. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. 1991 BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA. 88:6961-6965.
12. Le Brun DP, Warnke RA, Cleary ML. 1993 Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol. 142:743-753.
13. Lu QL, Poulsom R, Wong L, Hanby AM. 1993 BCL-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol. 169:431-437.
14. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. 1994 Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol. 145:515-525.
15. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R, Pierotti MA. 1994 Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol. 172:337-342.
16. Krajewski S, Blomqvist C, Franssila K, et al. 1995 Reduced expression of proapoptotic gene BAX is associated with poor response to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55:4471-4478.
17. Krajewski S, Krajewska M, Shabaik A, et al. 1994 Immunohistochemical analysis of in vivo patterns of bcl-X expression. Cancer Res. 54:5501-5507.
18. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. 1994 Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl2. Am J Pathol. 145:1323-1336.
19. Hedlinger CE. 1988 Histological typing of thyroid tumours. In: Hedlinger CE, ed. International Histological Classification of Tumours. Berlin: Springer Verlag; vol 2:1-66.
20. Pezzela F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. 1990 Expression of the bcl-2 protein is not specific for the 14;18 chromosomal translocation. Am J Pathol. 137:225-232.
21. Shi SR, Key ME, Kalra KL. 1991 Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 39:741-748.
22. Schlaifer D, March M, Krajewski S, et al. 1995 High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood. 85:2671-2674.
23. Oltvai ZN, Korsmeyer SJ. 1994 Checkpoints of dueling dimers foil death wishes. Cell. 79:189-192.
24. Hermann MA, Hay ID, Bartelt, et al. 1991 Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest. 88:1596-1604.
25. Pezzella F, Gatter K. 1995 What is the value of Bcl-2 protein detection for histopathologists? Histopathology. 26:89-93.
26. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA. 1993 Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest. 91:1753-1760.
27. Dobashi Y, Sakamoto A, Sugimura H, et al. 1993 Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol. 17:375-380,
28. Miyashita T, Krajewski S, Krajewska M, et al. 1994 Tumor suppressor gene p53 is a regulator of bcl-2 and bax gene expression in vivo and in vivo. Oncogene. 9:1799-1805.
29. Fraurnan AG, Moses AC. 1990 Oncogenes and growth factors in thyroid carcinogenesis. In: Kaplan MM, ed. Endocrinology and Metabolism Clinics of North America. Philadelphia: Saunders; vol 19:479-493.
30. Haugen DR, Aksklen LA, Varhaug JE, Lillehaug JR. 1993 Demonstration of a TGF-alpha-EGF receptor autocrine loop and c-myc protein over expression in papillary thyroid carcinomas. Int J Cancer. 55:37-43.
31. Bissonnette RP, Echeverri F, Mahbouri A, Green DR. 1992 Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:552-554.